Real World Treatment Patterns and Treatment Persistence Among Ulcerative Colitis and Crohn's Disease Patients in the Corrona Inflammatory Bowel Disease National Registry

被引：0
作者：
Sauk, Jenny S. [1 ]
Horst, Sara [2 ]
Hudesman, David P. [3 ]
Zhuo, Joe [4 ]
Ahmad, Harris [4 ]
Sreih, Antoine [4 ]
Harrison, Ryan W. [5 ]
Mackey, Rachel H. [5 ]
Crabtree, Margaux [5 ]
Emeanuru, Kelechi [5 ]
Cross, Raymond K. [6 ]
机构：
[1] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] NYU, Sch Med, NYU Langone Hlth, Ctr Inflammatory Bowel Dis, New York, NY USA
[4] Bristol Myers Squibb, Lawrence Township, NJ USA
[5] Corrona LLC, Waltham, MA USA
[6] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S0878
引用
收藏
页码：S452 / S453
页数：2
相关论文
共 50 条
  • [21] Characteristics of Crohn's Disease Patients in the Corrona Inflammatory Bowel Disease Registry on Biological or Conventional Therapy Differ by Disease Duration
    Abraham, Bincy P.
    Hunter, Theresa M.
    Naegeli, April N.
    Shan, Mingyang
    Sontag, Angelina
    Moore, Page C.
    Mackey, Rachel H.
    Crabtree, Margaux
    Korzenik, Joshua R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S364 - S364
  • [22] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Brian Bressler
    Jennifer Jones
    Tracy S. H. In
    Tommy Lan
    Cristian Iconaru
    John K. Marshall
    Advances in Therapy, 2023, 40 : 4421 - 4439
  • [23] Chronic inflammatory intestinal diseases:Crohn's disease and ulcerative colitis.: Part 2:: Imaging of ulcerative colitis,treatment of Crohn's disease and ulcerative colitis
    Feuerbach, S
    Scholmerich, J
    RADIOLOGE, 2000, 40 (04): : 415 - 428
  • [24] Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis
    Toruner, M.
    Guvenir, T.
    Er, R. E.
    Soykan, I.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 531 - 532
  • [25] Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn's disease
    Hunter, Theresa
    Komocsar, Wendy J.
    Colletti, Richard B.
    Liu, Chunyan
    Benkov, Keith J.
    Dotson, Jennifer L.
    Steiner, Steven J.
    Zhang, Nanhua
    Crandall, Wallace
    Network, ImproveCareNow
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (01) : 63 - 69
  • [26] Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis
    Gonzalez-Lama, Yago
    Sanz, Jesus
    Bastida, Guillermo
    Campos, Jose
    Ferreiro, Rocio
    Joven, Beatriz
    Gutierrez, Ana
    Juanola, Xavier
    Sicilia, Beatriz
    Veroz, Raul
    Gisbert, Javier P.
    Chaparro, Maria
    Domenech, Eugeni
    Esteve, Maria
    Gomollon, Fernando
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (05): : 273 - 283
  • [27] Characteristics of Patients With Crohn's Disease by History of Perianal Fistula Who Enrolled in the Corrona® Inflammatory Bowel Disease Registry
    Fan, Yanni
    Golembesky, Amanda
    Moore, Page C.
    Crabtree, Margaux
    Mackey, Rachel H.
    Delgado, Silvia
    Valdecantos, Wendell
    Stidham, Ryan W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S438 - S439
  • [28] Inflammatory bowel diseases. Crohn's disease and ulcerative colitis
    Fischer, S.
    Rath, T.
    Neurath, M. F.
    INTERNIST, 2018, 59 (07): : 681 - 692
  • [29] Vedolizumab for the treatment of ulcerative colitis and Crohn's disease
    McLean, Leon P.
    Shea-Donohue, Terez
    Cross, Raymond K.
    IMMUNOTHERAPY, 2012, 4 (09) : 883 - 898
  • [30] Aminosalicylates in the treatment of ulcerative colitis and Crohn's disease
    Sutherland, LR
    ADVANCES IN INFLAMMATORY BOWEL DISEASES, 1999, 106 : 201 - 209
12345